IRS 19 increases the specific and nonspecific immunity. When spraying IRS 19 is formed a fine aerosol that covers the nasal mucosa, which leads to rapid development of the local immune response. Specific protection is locally formed antibodies class of secretory immunoglobulin type A(IgA), preventing the fixation and reproduction of infectious agents in the mucosa. Nonspecific immunotoxic manifests itself in the enhancement of the phagocytic activity of macrophages and increasing the content of lysozyme.

Indications:

• prevention of chronic diseases of the upper respiratory tract and bronchi
  
• treatment of acute and chronic diseases of the upper respiratory tract and bronchi (rhinitis, sinusitis, laryngitis, pharyngitis, tonsillitis, tracheitis, bronchitis), etc.
  
• the restoration of local immunity after an influenza and other viral infections
  
• preparations for the planned rapid intervention in ENT organs and in the postoperative period.